Curis
CRIS
#11067
Rank
HK$35.01 M
Marketcap
HK$3.68
Share price
-23.59%
Change (1 day)
-58.17%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -HK$67.02 Million

According to Curis's latest financial reports the company's current earnings are HK$4.31 Million. In 2025 the company made an earning of -HK$42.32 Million, an increase over its 2024 earnings that were of -HK$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$67.02 Million58.37%
2025 -HK$42.32 Million-87.38%
2024 -HK$0.34 Billion-5.77%
2023 -HK$0.36 Billion-13.1%
2022 -HK$0.41 Billion27.52%
2021 -HK$0.33 Billion65.09%
2020 -HK$0.2 Billion-9.1%
2019 -HK$0.22 Billion-4.73%
2018 -HK$0.23 Billion-41.95%
2017 -HK$0.39 Billion-14.37%
2016 -HK$0.46 Billion3.55%
2015 -HK$0.44 Billion271.52%
2014 -HK$0.12 Billion76.64%
2013 -HK$66.5 Million
2011 -HK$56.48 Million27.76%
2010 -HK$44.21 Million-43.87%
2009 -HK$78.77 Million-23.44%
2008 -HK$0.11 Billion56.66%
2007 -HK$65.67 Million-16.71%
2006 -HK$78.85 Million-36.92%
2005 -HK$0.13 Billion156.25%
2004 -HK$48.78 Million-37.24%
2003 -HK$77.73 Million-93.34%
2002 -HK$1.17 Billion86.79%
2001 -HK$0.63 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$54.63 B-82,581.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$88.85 B-134,238.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$0.49 Billion 632.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$8.35 B-12,716.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$2.56 Billion 3,756.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-HK$0.18 Billion 163.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-HK$1.53 Billion 2,203.50%๐Ÿ‡บ๐Ÿ‡ธ USA